deaths (OS)

mNSCLC - L1 - all population metastatic/advanced NSCLC (mNSCLC) - 1st line (L1) mNSCLC - L1 - all population

versus Standard of Care (SoC)
durvalumab alone vs. Standard of Care (SoC) 1 0.96 [0.81; 1.13], 1 RCT, I2=0%
inconclusive result